Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders

International Journal of Fertility and Women's Medicine

Volumn 46, Issue 4, 2001, Pages 228-231

  Alpay, Fatma Betul ^a   Turhan, Nilgun Ozturk ^a  

^a BILKENT UNIVERSITY   (Turkey)

Author keywords

Depression; Premenstrual dysphoric disorder; Sertraline

Indexed keywords

SERTRALINE;

ADULT; ANOREXIA; ANXIETY NEUROSIS; ARTICLE; DEPRESSION; DRUG INTERMITTENT THERAPY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; NAUSEA; NEUROSIS; OBSESSION; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; SLEEP DISORDER; STOMACH PAIN;

ADULT; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0035412482     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Breaux C, Hertlage S, Gehlert S: Relationships of PMDD to major depression and anxiety disorders. A recom-examination. J Psychosom Obstet Gynecol 21(1):17-24, 2000.
2. Yonkers KA: Anxiety symptoms are anxiety disorders. How are they related to premenstrual disorders? J Clin Psychiatry 58(Suppl 3):62-67, 1997.
3. Culov-Sumic J: Sertraline in the treatment of PMDD. Lijec Vjesn 121(7-8):234-238, 1999.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC, pp 715-718, 1994.
5. Eriksson E: Serotonin reuptake inhibitor for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 14(Suppl 2):27-33, 1999.
6. Young SA: Treatment of PMDD with sertraline during the luteal phase: A randomized, double blind, placebo-controlled crossover trial. J Clin Psychiatry 59(2):76-80, 1998.
7. Pearlstein TB, Halbrich U, Batzer ED: Psychosocial functioning in women with PMDD before and after treatment with sertraline or placebo. J Clin Psychiatry 61(2):101-109, 2000.
8. Williams BW: A structured interview guide for Hamilton Depression Rating Scale. Arch Gen Psychiatry 45:742-747, 1978.
9. Akdemir A, Orsel S, Dag I: Validity, reliability and clinical use of Hamilton Depression Rating Scale. Pscyhiatry, Psychology and Psychofarm J (in Turkish) 4(4):251-259, 1996.
10. Pearlstein T, Stone AB: Premenstrual syndrome. Psychiatr Clin North Am 21(3):577-590, 1998.
11. Halbreich U: PMDD: A diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 95:169-176, 1997.
12. Rubinow DR, Schmidt PJ: The treatment of PMDD: Forward into the past. N Engl J Med 332:1574-1575, 1995.
13. Freeman EW: Differential response to antidepressants in women with PMS/PMDD: A randomized controlled trial. Arch Gen Psychiatry 56(10):932-939, 1999.
14. Halbreich U: Intermittent luteal phase sertraline treatment of dysphoric PMS. J Clin Psychiatry 58(9):339-402, 1997.
15. Yonkers KA: Symptomatic improvement of PMDD with sertraline treatment. A randomized controlled trial. JAMA 278(12):983-988, 1997.
16. Jerman DM: Luteal phase sertraline treatment for PMDD. Results of a double-blind, placebo-controlled crossover study. Arch Fem Med 8(4):328-332, 1999.
17. Kaplan and Sadock's Synopsis of Psychiatry. Biological Therapies, Mass Publishing, pp 932-1122, 1998.
18. Endicott J: Differential diagnoses and co-morbidity, in Gold J, Severino ST (eds): Premenstrual Dysphorias: Myth and Realities. Washington, DC, American Psychiatric Association, pp 3-17, 1994.